The impact of Brexit on Pharma, Life Science and MedTech companies – A PwC Pharma & Life Sciences Webinar

Dear pharma & life sciences colleagues

Brexit is coming closer every day with many aspects still unclear which makes it hard for you to prepare for it.

We’re excited to take a closer look at the current status quo and the impact of Brexit on indirect taxes, movement of goods and trade for Pharma, Life Sciences and MedTech Companies.

Continue reading The impact of Brexit on Pharma, Life Science and MedTech companies – A PwC Pharma & Life Sciences Webinar

OFAC fined US subsidiary of Austrian ERBER Group after misinterpreting US Sanctions

Animal nutrition company BIOMIN America was fined by more than $250’000 for coordinating sales of agricultural commodities to a company in Cuba without authorization from OFAC (US Office of Foreign Assets Controls).

Continue reading OFAC fined US subsidiary of Austrian ERBER Group after misinterpreting US Sanctions